Atria Wealth Solutions Inc. Sells 406 Shares of Align Technology, Inc. (NASDAQ:ALGN)

Atria Wealth Solutions Inc. decreased its holdings in Align Technology, Inc. (NASDAQ:ALGN) by 35.6% in the first quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The institutional investor owned 736 shares of the medical equipment provider’s stock after selling 406 shares during the period. Atria Wealth Solutions Inc.’s holdings in Align Technology were worth $246,000 as of its most recent SEC filing.

A number of other institutional investors and hedge funds have also modified their holdings of the business. Manchester Capital Management LLC bought a new stake in shares of Align Technology in the first quarter worth $26,000. KB Financial Partners LLC bought a new stake in shares of Align Technology in the first quarter worth $26,000. CVA Family Office LLC grew its holdings in shares of Align Technology by 46.7% in the first quarter. CVA Family Office LLC now owns 110 shares of the medical equipment provider’s stock worth $37,000 after acquiring an additional 35 shares during the period. First Manhattan CO. LLC. grew its holdings in shares of Align Technology by 593.8% in the first quarter. First Manhattan CO. LLC. now owns 111 shares of the medical equipment provider’s stock worth $37,000 after acquiring an additional 95 shares during the period. Finally, Ameritas Advisory Services LLC bought a new stake in shares of Align Technology in the first quarter worth $41,000. Institutional investors own 87.07% of the company’s stock.

Analyst Ratings Changes

Several brokerages recently commented on ALGN. StockNews.com began coverage on Align Technology in a report on Thursday, August 17th. They issued a “buy” rating for the company. OTR Global raised Align Technology from a “mixed” rating to a “positive” rating in a report on Thursday, September 14th. Piper Sandler boosted their price target on Align Technology from $370.00 to $415.00 in a report on Thursday, July 27th. Morgan Stanley boosted their price target on Align Technology from $383.00 to $415.00 and gave the company an “overweight” rating in a report on Thursday, July 27th. Finally, HSBC started coverage on Align Technology in a report on Wednesday, August 30th. They set a “buy” rating and a $450.00 price target for the company. Two investment analysts have rated the stock with a hold rating and eight have issued a buy rating to the company’s stock. Based on data from MarketBeat, the company presently has an average rating of “Moderate Buy” and an average price target of $380.33.

Align Technology Stock Down 2.0 %

Shares of Align Technology stock opened at $325.32 on Tuesday. The stock’s 50-day simple moving average is $354.79 and its 200-day simple moving average is $331.92. Align Technology, Inc. has a 52 week low of $172.05 and a 52 week high of $413.20. The company has a market capitalization of $24.90 billion, a price-to-earnings ratio of 79.93, a PEG ratio of 2.64 and a beta of 1.63.

Align Technology (NASDAQ:ALGN) last announced its quarterly earnings results on Wednesday, July 26th. The medical equipment provider reported $1.73 EPS for the quarter, beating analysts’ consensus estimates of $1.64 by $0.09. Align Technology had a return on equity of 11.42% and a net margin of 8.40%. The company had revenue of $1 billion during the quarter, compared to analyst estimates of $985.87 million. On average, equities analysts expect that Align Technology, Inc. will post 7.2 earnings per share for the current year.

Align Technology Company Profile

Align Technology, Inc designs, manufactures, and markets Invisalign clear aligners, and iTero intraoral scanners and services for orthodontists and general practitioner dentists in the United States, Switzerland, China, and internationally. It operates in two segments, Clear Aligner; and Imaging Systems and CAD/CAM Services (Systems and Services).